Stolper CO Abb Vie Inc. Transaction History

Stolper CO

$306 Million
Q3 2024

A detailed history of Stolper CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Stolper CO holds 14,438 shares of ABBV stock, worth $2.4 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares

14,438

Previous 14,502 0.44%

Holding current value

$2.4 Million

Previous $2.49 Million 14.64%

% of portfolio

0.93%

Previous 0.88%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	SELL	$163.84 - $199.33 $10,485 - $12,757	-64 Reduced 0.44%	14,438 $2.85 Million
Q2 2024 Aug 08, 2024	SELL	$154.79 - $180.76 $4,953 - $5,784	-32 Reduced 0.22%	14,502 $2.49 Million
Q1 2024 Apr 09, 2024	BUY	$159.82 - $182.1 $3,036 - $3,459	19 Added 0.13%	14,534 $2.65 Million
Q4 2023 Jan 12, 2024	SELL	$137.6 - $154.97 $29,721 - $33,473	-216 Reduced 1.47%	14,515 $2.25 Million
Q3 2023 Oct 10, 2023	SELL	$133.59 - $154.65 $16,431 - $19,021	-123 Reduced 0.83%	14,731 $2.2 Million
Q2 2023 Jul 10, 2023	SELL	$132.51 - $164.9 $16,961 - $21,107	-128 Reduced 0.85%	14,854 $2 Million
Q1 2023 Apr 11, 2023	SELL	$144.61 - $166.54 $14,171 - $16,320	-98 Reduced 0.65%	14,982 $2.39 Million
Q4 2022 Jan 11, 2023	SELL	$138.31 - $165.87 $479,797 - $575,403	-3,469 Reduced 18.7%	15,080 $2.44 Million
Q3 2022 Oct 07, 2022	BUY	$134.21 - $153.93 $124,412 - $142,693	927 Added 5.26%	18,549 $2.49 Million
Q2 2022 Jul 08, 2022	SELL	$137.62 - $174.96 $97,710 - $124,221	-710 Reduced 3.87%	17,622 $2.7 Million
Q1 2022 Apr 14, 2022	BUY	$131.98 - $163.75 $46,193 - $57,312	350 Added 1.95%	18,332 $2.97 Million
Q4 2021 Jan 11, 2022	BUY	$107.43 - $135.93 $537 - $679	5 Added 0.03%	17,982 $2.44 Million
Q3 2021 Oct 13, 2021	BUY	$106.4 - $120.78 $20,960 - $23,793	197 Added 1.11%	17,977 $1.94 Million
Q2 2021 Jul 15, 2021	BUY	$105.21 - $117.21 $11,783 - $13,127	112 Added 0.63%	17,780 $2 Million
Q1 2021 Apr 09, 2021	SELL	$102.3 - $112.62 $17,493 - $19,258	-171 Reduced 0.96%	17,668 $1.91 Million
Q4 2020 Jan 11, 2021	BUY	$80.49 - $108.67 $21,973 - $29,666	273 Added 1.55%	17,839 $1.91 Million
Q3 2020 Oct 08, 2020	SELL	$85.91 - $100.83 $261,510 - $306,926	-3,044 Reduced 14.77%	17,566 $1.54 Million
Q2 2020 Jul 09, 2020	SELL	$73.37 - $98.18 $113,650 - $152,080	-1,549 Reduced 6.99%	20,610 $2.02 Million
Q1 2020 Apr 14, 2020	BUY	$64.5 - $97.79 $1.43 Million - $2.17 Million	22,159 New	22,159 $1.69 Million

Others Institutions Holding ABBV

# of Institutions

3,843

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $294B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stolper CO, based on Form 13F filings with the SEC.

News

Stay updated on Stolper CO with notifications on news.

Account